AllianceBernstein’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

AllianceBernstein’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-938,877	Closed	-$58.4M	–	3207
2023 Q4	$58.4M	Sell	938,877 -295,759	-24%	-$7.35M	0.02%	542
2023 Q3	$27.4M	Buy	+1,234,636	New	+$25.9M	0.01%	746

AllianceBernstein's RYZB Position: Q1 2024 in Review

AllianceBernstein sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 938,877 shares — an estimated $58.4M sold.

AllianceBernstein first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $58.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

AllianceBernstein reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AllianceBernstein sold 938,877 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $58.4M.
AllianceBernstein first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
AllianceBernstein's RayzeBio, Inc. Common Stock position peaked at $58.4M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.